NCT03618758 2023-12-05
IPLUS
Seoul National University Bundang Hospital
Phase 1/2 Completed
Clinical Trials
8 trialsNCT02263495 2020-07-14
EG_PG
Asan Medical Center
Phase 2 Completed
NCT00882973 2017-05-05
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed
NCT00876486 2017-05-01
Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer
Samyang Biopharmaceuticals Corporation
Phase 3 Completed
NCT02064829 2016-03-25
TRIBECA
Sorrento Therapeutics, Inc.
Phase NA Completed
NCT00877253 2012-06-12
Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed
NCT00111904 2011-12-14
Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01426126 2011-12-07
Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum
Asan Medical Center
Phase 2 Completed